121 related articles for article (PubMed ID: 32654880)
1. Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety.
Mathon B; Le Joncour A; Bielle F; Mokhtari K; Boch AL; Peyre M; Amoura Z; Cacoub P; Younan N; Demeret S; Shotar E; Burrel S; Fekkar A; Robert J; Amelot A; Pineton de Chambrun M;
Eur J Intern Med; 2020 Oct; 80():78-85. PubMed ID: 32654880
[TBL] [Abstract][Full Text] [Related]
2. Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield.
Mathon B; Favreau M; Degos V; Amelot A; Le Joncour A; Weiss N; Rohaut B; Le Guennec L; Boch AL; Carpentier A; Bielle F; Mokhtari K; Idbaih A; Touat M; Combes A; Demoule A; Shotar E; Navarro V; Raux M; Demeret S; Pineton De Chambrun M;
Crit Care Med; 2022 Jun; 50(6):e516-e525. PubMed ID: 34995211
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity.
Chabaane M; Amelot A; Riche M; Bielle F; Mokhtari K; Carpentier A; Touat M; Mathon B
J Clin Neurol; 2020 Oct; 16(4):659-667. PubMed ID: 33029973
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value and Safety of Brain Biopsy in Patients With Cryptogenic Neurological Disease: A Systematic Review and Meta-analysis of 831 Cases.
Bai HX; Zou Y; Lee AM; Lancaster E; Yang L
Neurosurgery; 2015 Aug; 77(2):283-95; discussion 295. PubMed ID: 25856111
[TBL] [Abstract][Full Text] [Related]
5. Impact of brain biopsy on the management of patients with nonneoplastic undiagnosed neurological disorders.
Pulhorn H; Quigley DG; Bosma JJ; Kirollos R; du Plessis DG; Jenkinson MD
Neurosurgery; 2008 Apr; 62(4):833-7; discussion 837-8. PubMed ID: 18496189
[TBL] [Abstract][Full Text] [Related]
6. Brain biopsy in suspected non-neoplastic neurological disease.
Noronha C; Figueiredo G; Pinheiro C; Carvalho E; Calheiros A; Pires MM; Taipa R
Acta Neurochir (Wien); 2019 Jun; 161(6):1139-1147. PubMed ID: 31016453
[TBL] [Abstract][Full Text] [Related]
7. Brain biopsy in neurological disease of unknown etiology: A single-center 12-year retrospective analysis.
Lockhart A; Heffernan J; Kennedy A; Walsh A; Heeney C; Cheung R; Howley R; Cryan J; Beausang A; Farrell M; Brett F
Clin Neuropathol; 2023; 42(3):93-99. PubMed ID: 36970952
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic yield of brain biopsies in children presenting to neurology.
Venkateswaran S; Hawkins C; Wassmer E
J Child Neurol; 2008 Mar; 23(3):253-8. PubMed ID: 18192645
[TBL] [Abstract][Full Text] [Related]
9. Brain biopsy in cryptogenic neurological disease.
Rice CM; Gilkes CE; Teare E; Hardie RJ; Scolding NJ; Edwards RJ
Br J Neurosurg; 2011 Oct; 25(5):614-20. PubMed ID: 21501048
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of frameless and frame-based intracranial biopsy techniques.
Dammers R; Haitsma IK; Schouten JW; Kros JM; Avezaat CJ; Vincent AJ
Acta Neurochir (Wien); 2008 Jan; 150(1):23-9. PubMed ID: 18172567
[TBL] [Abstract][Full Text] [Related]
11. The utility of brain biopsy in pediatric cryptogenic neurological disease.
Layard Horsfall H; Toescu SM; Grover PJ; Hassell J; Sayer C; Hemingway C; Harding B; Jacques TS; Aquilina K
J Neurosurg Pediatr; 2020 Jul; 26(4):431-438. PubMed ID: 32619987
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of etiological diagnostic workup across the past 10 years in patients with spontaneous intracerebral hemorrhage in a large general hospital.
Wang Q; Lin S; Dong W; Liu M
Dev Neurorehabil; 2016; 19(1):10-6. PubMed ID: 24483215
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of brain biopsy in the diagnosis of severe neurologic disease of unknown etiology.
Burns JD; Cadigan RO; Russell JA
Clin Neurol Neurosurg; 2009 Apr; 111(3):235-9. PubMed ID: 19022558
[TBL] [Abstract][Full Text] [Related]
14. Factors Affecting the Diagnostic Yield of Frame-Based Stereotactic Intracranial Biopsies.
Maragkos GA; Penumaka A; Ahrendsen JT; Salem MM; Nelton EB; Alterman RL
World Neurosurg; 2020 Mar; 135():e695-e701. PubMed ID: 31883483
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous ultrasonography-guided core needle biopsy of gastrointestinal lesions: what's its actual role in clinical practice? A retrospective study for safety and effectiveness.
Tombesi P; Postorivo S; Catellani M; Tassinari D; Abbasciano V; Sartori S
Ultraschall Med; 2011 Jan; 32 Suppl 1():S62-7. PubMed ID: 20235004
[TBL] [Abstract][Full Text] [Related]
16. Frameless robotic stereotactic biopsies: a consecutive series of 100 cases.
Lefranc M; Capel C; Pruvot-Occean AS; Fichten A; Desenclos C; Toussaint P; Le Gars D; Peltier J
J Neurosurg; 2015 Feb; 122(2):342-52. PubMed ID: 25380111
[TBL] [Abstract][Full Text] [Related]
17. Safety and diagnostic value of brain biopsy in HIV patients: a case series and meta-analysis of 1209 patients.
Lee AM; Bai HX; Zou Y; Qiu D; Zhou J; Martinez-Lage Alvarez M; Zhang P; Tao Y; Tang X; Xiao B; Yang L
J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):722-33. PubMed ID: 26758989
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Severe Bleeding Complications in Percutaneous Renal Biopsy.
Xu DM; Chen M; Zhou FD; Zhao MH
Am J Med Sci; 2017 Mar; 353(3):230-235. PubMed ID: 28262208
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment.
Kim JE; Kim DG; Paek SH; Jung HW
Acta Neurochir (Wien); 2003 Jul; 145(7):547-54; discussion 554-5. PubMed ID: 12910397
[TBL] [Abstract][Full Text] [Related]
20. Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion.
Jain D; Sharma MC; Sarkar C; Deb P; Gupta D; Mahapatra AK
Brain Tumor Pathol; 2006 Oct; 23(2):71-5. PubMed ID: 18095122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
